NCT01296269

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior in Healthy Controls

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Hadassah Medical Organization · Academic / Other
• Sex: All
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the role of a one-time intranasal administration of the oxytocin, vasopressin, or placebo on prosocial decision making such as cooperation and altruism in a healthy population of student controls.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Oxytocin	one-time intranasal administration, 24 International Units, 5 puffs for each nostril
DRUG	Arginine Vasopressin	one-time intranasal administration, 20 International Units, 5 puffs in each nostril
DRUG	placebo	contains all the ingredients as in the oxytocin and vasopressin conditions, save for the active ingredient, one time intranasal administration, 5 puffs in each nostril

Timeline

• Start date: 2011-04-01
• Primary completion: 2012-05-01
• First posted: 2011-02-15
• Last updated: 2011-04-08

Locations

1 site across 1 country: Israel